Index of reports
> Cases with Skin Tightness (78)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Optimark (Gadoversetamide) where reactions include skin tightness. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 78 Next >>
Possible Optimark side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: male, weighing 91.0 kg (200.2 pounds)
Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Fatigue, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Dosage: 15 ml, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Prohance
Dosage: unk unk, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Gadolinium IN Unspecified Drug
Indication: Osteomyelitis
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk unk, once
Start date: 2005-01-25
End date: 2005-01-25
Omniscan
Indication: Angiogram
Optimark
Indication: Angiogram
Magnevist
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-15
End date: 2002-11-15
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Indication: Diabetic Foot
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-05
End date: 2002-11-05
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2005-01-14
End date: 2005-01-14
Magnevist
Dosage: 19 ml, once
Start date: 2004-07-16
End date: 2004-07-16
Other drugs received by patient: Clonidine; Fosrenol; Accupril; Renagel; Phoslo; Diatx; Vitamins NOS; Temazepam; Novolin R; Minoxidil; Insulin [insulin]; Coumadin; Procrit; Lasix
Possible Optimark side effects in 49 year old male
Reported by a lawyer from United States on 2012-08-02
Patient: 49 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Pain, Joint Contracture, Erythema, Muscle Tightness, Joint Stiffness, Myosclerosis, Rash Pruritic, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Depression, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Skin Tightness, Skin Plaque, Joint Swelling, Quadriparesis, Mobility Decreased
Drug(s) suspected as cause:
Omniscan
Multihance
Indication: Product Used FOR Unknown Indication
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-05-19
End date: 2006-05-19
Magnevist
Dosage: 15 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-10-13
End date: 2006-10-13
Omniscan
Dosage: 50 ml omniscan+co2
Indication: Fistulogram
Start date: 2006-08-04
End date: 2006-08-04
Gadolinium IN Unspecified Drug
Start date: 2004-05-19
End date: 2004-05-19
Omniscan
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-08-05
End date: 2006-08-05
Prohance
Indication: Computerised Tomogram Head
Start date: 2004-05-19
End date: 2004-05-19
Optimark
Indication: Product Used FOR Unknown Indication
Magnevist
Dosage: 20 ml, unk
Start date: 2006-10-17
End date: 2006-10-17
Other drugs received by patient: Coumadin; Renagel; Aranesp; Lyrica; Norvasc; Lamisil; Percocet; Gentamicin; Procardia XL; Ferrous Sulfate TAB; Sodium Bicarbonate; Acetaminophen; Venofer; Coreg; Actos; Prinivil; Synthroid; Amitriptline Hydrochloride TAB; Nateglinide; Pentoxifylline; Phoslo; Procrit; Epogen; Nexium; Elavil; Lipitor; Lantus; Trental; Benadryl; Avelox; Pletal; Tambocor; Atenolol; Zyvox; Lopid; Nephrocaps; Bactrim DS; Restoril; Clonidine; Starlix; Accupril; Vancomycin; Lasix; Potassium Chloride; Glucotrol; Renagel; Nicotine
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient: 56 year old female
Reactions: Pruritus, Abasia, Pain, Joint Contracture, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Injury, Fibrosis, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Rash, Skin Induration, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Mobility Decreased, Scar
Drug(s) suspected as cause:
Optimark
Indication: Muscular Weakness
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-05-28
End date: 1999-05-28
Optimark
Indication: Disorientation
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Indication: Headache
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Magnevist
Indication: Renal Mass
Other drugs received by patient: Lantus; Sensipar; Slow Release Iron; Prograf; Phoslo; Renvela; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Prednisone; Procrit; Atenolol
Possible Optimark side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient: female
Reactions: Pruritus, Pain, Joint Contracture, Myosclerosis, Skin Ulcer, Injury, Fibrosis, General Physical Health Deterioration, Skin Hypertrophy, Skin Induration, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Tendon Disorder, Disability
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Multihance
Indication: Angiogram
Omniscan
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24
Patient: 56 year old female
Reactions: Pruritus, Abasia, Joint Contracture, Pain, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Fibrosis, Injury, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, DRY Skin, Nephrogenic Systemic Fibrosis, Rash, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Scar, Mobility Decreased
Drug(s) suspected as cause:
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Muscular Weakness
Optimark
Indication: Headache
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-05-28
End date: 1999-05-28
Magnevist
Indication: Renal Mass
Optimark
Indication: Disorientation
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-05-21
End date: 2004-05-21
Other drugs received by patient: Sensipar; Renvela; Prograf; Prednisone; Procrit; Phoslo; Lantus; Slow Release Iron; Atenolol; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]
Possible Optimark side effects in 79 year old female
Reported by a physician from United States on 2012-07-20
Patient: 79 year old female, weighing 63.6 kg (140.0 pounds)
Reactions: Skin Wrinkling, Pruritus, Pain, Muscle Rigidity, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Oedema, Injury, Extremity Contracture, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Emotional Distress, Anxiety, Arthralgia
Adverse event resulted in: death
Drug(s) suspected as cause:
Omniscan
Dosage: dose reported as eight 20ml vials (160ml)
Start date: 2005-09-20
End date: 2005-09-20
Multihance
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Prohance
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Multihance
Indication: Angiogram
Gadolinium Zeolite
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-04-25
End date: 2001-04-25
Gadolinium Zeolite
Start date: 2005-08-16
End date: 2005-08-16
Omniscan
Dosage: route reported as ^first via distal port and then via the proximal port^
Indication: Angiogram
Start date: 2003-12-04
End date: 2003-12-04
Optimark
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2005-08-16
End date: 2005-08-16
Optimark
Indication: Angiogram
Gadolinium Zeolite
Start date: 2001-05-03
End date: 2001-05-03
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-04-25
End date: 2001-04-25
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium Zeolite
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2001-03-05
End date: 2001-03-05
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2003-05-23
End date: 2003-05-23
Prohance
Indication: Angiogram
Magnevist
Indication: Angiogram
Start date: 2001-05-03
End date: 2001-05-03
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: dose reported as ^11^ 20ml vials
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-01
End date: 2005-09-01
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Epogen; Imdur; Folic Acid; Potassium Chloride; Lovastatin; Diltiazem; Furosemide; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Potassium Chloride; Amiodarone HCL; Hydralazine HCL; Aspirin; Niferex; Coreg; Plendil; Venofer; Zemplar
Possible Optimark side effects in 44 year old female
Reported by a physician from United States on 2012-07-18
Patient: 44 year old female, weighing 130.0 kg (286.0 pounds)
Reactions: Pain, Fear, Scleroderma, Hand Deformity, Skin Discolouration, Oedema, Musculoskeletal Stiffness, Injury, Systemic Sclerosis, Pain of Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Sclerodactylia, Anxiety, Emotional Distress, Arthralgia, Gait Disturbance, Mobility Decreased
Drug(s) suspected as cause:
Optimark
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-02-06
Optimark
Dosage: unk
Indication: Angiogram
Start date: 2005-05-31
Optimark
Dosage: unk
Start date: 2005-08-31
Other drugs received by patient: Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Coumadin; Accupril; Atenolol; Epogen; Renagel; Calcitriol; Diovan; Norvasc
Possible Optimark side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12
Patient: 58 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Disorder, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Skin Hypertrophy, Deformity, Skin Plaque, Skin Tightness, Gait Disturbance, Skin Fibrosis, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Dosage: 20 ml, once
Start date: 2005-05-19
End date: 2005-05-19
Magnevist
Dosage: unk
Indication: Computerised Tomogram Abdomen
Start date: 2004-10-03
End date: 2004-10-03
Magnevist
Dosage: unk
Start date: 2004-11-10
End date: 2004-11-10
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-20
End date: 2005-05-20
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-01-15
End date: 2004-01-15
Magnevist
Dosage: unk
Start date: 2004-07-01
End date: 2004-07-01
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Gadolinium IN Unspecified Drug
Indication: Angiogram
Magnevist
Dosage: unk
Indication: Imaging Procedure
Start date: 2004-10-29
End date: 2004-10-29
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2005-02-17
End date: 2005-02-17
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-27
End date: 2003-09-27
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk
Start date: 2004-12-13
End date: 2004-12-13
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-31
End date: 2004-10-31
Other drugs received by patient: Sensipar; Ativan; Lisinopril; Loperamide; Folic Acid; Tylenol W / Codeine NO. 3; Magnesium Oxide; Plavix; Epogen; Calcijex; Zosyn; Ambien; Vitamin K1; Clonidine; Albumin (Human); Roxanol; Velcade; Adenosine; Aspirin; Dexamethasone; Acetaminophen; Compazine; Dilaudid; Foltx; Diflucan; Vancomycin; Potassium Chloride; Bactrim DS; Ciprofloxacin HCL; Hydroxyzine; Acyclovir; Mucomyst; Biaxin; Metoprolol Tartrate; Atarax; Cyclophosphamide; Norco; Neurontin; Digoxin; Ativan; Prevacid; Dexamethasone; Zoloft; Vitamin K1; Ocean; Senokot; Neupogen; Bicitra; Allopurinol; Pravachol; Levaquin; Phoslo; Gentamicin; Nephrocaps; Adriamycin PFS; Simethicone; Zemplar; Plendil; Midodrine Hydrochloride; Renaphro; Renagel; Ativan; Oxacillin; Etoposide; Reglan; Reglan; Compazine; Warfarin Sodium; Prograf
Possible Optimark side effects in 51 year old female
Reported by a lawyer from United States on 2012-07-09
Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)
Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Skin Fissures, Joint Stiffness, Skin Discolouration, Dermatitis, Joint Range of Motion Decreased, Oedema Peripheral, Skin Haemorrhage, Fibrosis, Injury, Pain in Extremity, Motor Dysfunction, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Sclerodactylia, Skin Tightness, Emotional Distress, Anxiety, Burning Sensation, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Fistulogram
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2001-01-11
End date: 2001-01-11
Optimark
Indication: Venogram
Multihance
Indication: Venogram
Magnevist
Indication: Arteriovenous Fistula Operation
Start date: 2006-11-28
End date: 2006-11-28
Prohance
Indication: Venogram
Prohance
Indication: Fistulogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk, once
Indication: Venous Pressure Increased
Start date: 2004-12-09
End date: 2004-12-09
Magnevist
Indication: Dialysis Efficacy Test
Start date: 2006-09-26
End date: 2006-09-26
Magnevist
Indication: Dialysis Device Insertion
Omniscan
Indication: Fistulogram
Optimark
Indication: Fistulogram
Omniscan
Indication: Venogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Levothroid; Atenolol; Phoslo; Epoetin NOS; PEG-3350 and Electrolytes; Levothroid; Calcium Carbonate; Renagel; Epogen; Procardia XL; Pravachol; Sensipar; Vitamin B12; Imodium; Cardizem; Prednisone; Amiodarone HCL; Allopurinol; Immune Globulin NOS; Benadryl; Omeprazole; Protonix; Renagel; Plendil; Immune Globulin NOS; Acetaminophen; Pravastatin; Atenolol; Coumadin; Reglan; Vicodin; Nephro-Vite [vitamins Nos]; Immune Globulin NOS; Immune Globulin NOS; Acetaminophen; Nitroglycerin; Tramadol HCL; Coumadin; Calcium Carbonate; Sensipar; Cyclosporine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Fosrenol; Metoclopramide; Metoprolol Tartrate; Nifedipine; Acetaminophen; Benadryl; Ureacin; Loperamide; Corticosteroids; Coumadin; Protonix; Allopurinol; Prilosec; Immune Globulin NOS; Acetaminophen; Acetaminophen; Benadryl
Possible Optimark side effects in male
Reported by a consumer/non-health professional from United States on 2012-06-28
Patient: male, weighing 83.0 kg (182.6 pounds)
Reactions: Pruritus, Pain, Quality of Life Decreased, Muscular Weakness, Orthostatic Hypotension, DRY Skin, Stasis Dermatitis, Nephrogenic Systemic Fibrosis, Rash, Skin Hypertrophy, Skin Tightness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Mobility Decreased
Drug(s) suspected as cause:
Optimark
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Prohance
Indication: Angiogram
Magnevist
Indication: Angiogram
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Multihance
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Magnevist
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1998-05-18
End date: 1998-05-18
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Pepcid; Meclizine; Prednisone TAB; Diovan; Plavix; Nexium; Flomax; Warfarin Sodium; Covera-HS; Norvasc; Nephrocaps [vit C,vit H,b12,b9,b3,pantothen Ac,b6,b2,b1 Hcl]; Coumadin; Epogen; Monopril; Cytoxan; Accupril; Aspirin; Sensipar; Novolin [insulin]; Hydralazine Hydrochloride; Ancef; Acetaminophen; Kayexalate; Humulin [insulin Human Injection, Isophane]; Norvasc; Phoslo; Catapres; Prevacid; Renvela; Lasix; Amiodarone Hydrochloride; Ascorbic Acid; Fish OIL; Sodium Polystyrene Sulfonate; Procrit; Zaroxolyn; Diuril; Darvocet; Neurontin; Renagel; Clonidine; Levothyroxine; Demadex; Potassium Chloride; Verapamil; Percocet; Lopressor; Lipitor
Possible Optimark side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25
Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)
Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Deformity, Skin Plaque, Skin Tightness, Scar, Skin Fibrosis, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Computerised Tomogram Abdomen
Start date: 2004-10-03
End date: 2004-10-03
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-31
End date: 2004-10-31
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk
Indication: Imaging Procedure
Start date: 2004-10-29
End date: 2004-10-29
Magnevist
Dosage: unk
Start date: 2004-12-13
End date: 2004-12-13
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Magnevist
Dosage: unk
Start date: 2004-07-01
End date: 2004-07-01
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2005-02-17
End date: 2005-02-17
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-27
End date: 2003-09-27
Magnevist
Dosage: unk
Start date: 2004-11-10
End date: 2004-11-10
Magnevist
Dosage: 20 ml, once
Start date: 2005-05-19
End date: 2005-05-19
Gadolinium IN Unspecified Drug
Indication: Angiogram
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-01-15
End date: 2004-01-15
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-20
End date: 2005-05-20
Other drugs received by patient: Bicitra; Foltx; Plavix; Dexamethasone; Acetaminophen; Adriamycin PFS; Compazine; Dilaudid; Pravachol; Phoslo; Vitamin K1; Etoposide; Reglan; Hydroxyzine; Plendil; Neupogen; Acyclovir; Digoxin; Mucomyst; Renagel; Calcijex; Levaquin; Simethicone; Renaphro; Sensipar; Biaxin; Dexamethasone; Zosyn; Ciprofloxacin; Ocean; Loperamide; Senokot; Clonidine; Albumin (Human); Diflucan; Magnesium Oxide; Potassium Chloride; Gentamicin; Ambien; Compazine; Velcade; Adenosine; Ativan; Lisinopril; Epogen; Oxacillin; Reglan; Zemplar; Roxanol; Allopurinol; Tylenol W / Codeine NO. 3; Ativan; Zoloft; Nephrocaps; Vitamin K1; Cyclophosphamide; Norco; Midodrine Hydrochloride; Warfarin Sodium; Prograf; Folic Acid; Ativan; Aspirin; Prevacid; Metoprolol Tartrate; Vancomycin; Bactrim DS; Atarax; Neurontin
Possible Optimark side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06
Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)
Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Oedema, Musculoskeletal Stiffness, Fibrosis, Cellulitis, Pain of Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Hypertrophy, Rash, Deformity, Skin Tightness, Skin Plaque, Scar, Mobility Decreased, Skin Fibrosis
Drug(s) suspected as cause:
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-27
End date: 2003-09-27
Magnevist
Dosage: unk
Indication: Computerised Tomogram Abdomen
Start date: 2004-10-03
End date: 2004-10-03
Magnevist
Dosage: unk
Start date: 2004-11-10
End date: 2004-11-10
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-20
End date: 2005-05-20
Magnevist
Dosage: unk
Start date: 2004-12-13
End date: 2004-12-13
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Indication: Angiogram
Magnevist
Dosage: unk
Start date: 2004-07-01
End date: 2004-07-01
Magnevist
Dosage: unk
Indication: Imaging Procedure
Start date: 2004-10-29
End date: 2004-10-29
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2005-02-17
End date: 2005-02-17
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Magnevist
Dosage: 20 ml, once
Start date: 2005-05-19
End date: 2005-05-19
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-31
End date: 2004-10-31
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-01-15
End date: 2004-01-15
Other drugs received by patient: Ativan; Biaxin; Acetaminophen; Ciprofloxacin; Nephrocaps; Cyclophosphamide; Etoposide; Neupogen; Neurontin; Warfarin Sodium; Phoslo; Loperamide; Hydroxyzine; Acyclovir; Zoloft; Vitamin K1; Dilaudid; Albumin (Human); Midodrine Hydrochloride; Foltx; Digoxin; Pravachol; Dexamethasone; Epogen; Gentamicin; Ambien; Clonidine; Bicitra; Mucomyst; Magnesium Oxide; Calcijex; Zosyn; Vitamin K1; Adriamycin PFS; Ocean; Reglan; Compazine; Roxanol; Velcade; Allopurinol; Adenosine; Sensipar; Diflucan; Renagel; Ativan; Ativan; Prevacid; Bactrim DS; Simethicone; Norco; Prograf; Tylenol W / Codeine NO. 3; Dexamethasone; Reglan; Plendil; Renaphro; Folic Acid; Aspirin; Plavix; Lisinopril; Metoprolol Tartrate; Levaquin; Vancomycin; Potassium Chloride; Atarax; Oxacillin; Zemplar; Compazine; Senokot
Possible Optimark side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Pruritus, Hyperkeratosis, Pain, Skin Burning Sensation, Skin Hyperpigmentation, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Fibrosis, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, DRY Skin, Hypoaesthesia, Skin Induration, Deformity, Skin Tightness, Paraesthesia, Skin Plaque, Rash Macular, Gait Disturbance, Scar, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2005-04-14
End date: 2005-04-14
Omniscan
Dosage: 15 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-15
End date: 2004-10-15
Prohance
Dosage: 17 ml, once
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2003-07-03
End date: 2003-07-03
Magnevist
Omniscan
Dosage: 30 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-07-13
End date: 2004-07-13
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-04-14
End date: 2005-04-14
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Optimark
Multihance
Other drugs received by patient: Calcitriol; Plavix; Fosrenol; Sensipar; Clonidine; Renvela; Rena-Vite; Calcium Carbonate; Metoprolol Tartrate; Renagel; Cozaar; Phoslo; Epogen; Hectorol; Iron; Amlodipine; Lisinopril; Proamatine; Foltx
Possible Optimark side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-01
Patient: 54 year old male, weighing 93.9 kg (206.5 pounds)
Reactions: Hyperkeratosis, Skin Exfoliation, Pain, Skin Hyperpigmentation, Scleroderma, Erythema, Joint Range of Motion Decreased, Oedema Peripheral, Skin Swelling, Rash Papular, General Physical Health Deterioration, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Sclerodactylia, Skin Tightness, Macule, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 1999-10-13
End date: 1999-10-13
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2007-03-21
End date: 2007-03-21
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-11-18
End date: 2008-11-18
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 1999-10-28
End date: 1999-10-28
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-01-14
End date: 2006-01-14
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 1999-09-20
End date: 1999-09-20
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Fistulogram
Start date: 1999-10-08
End date: 1999-10-08
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-02-04
End date: 2006-02-04
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-03-19
End date: 2008-03-19
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-09-27
End date: 1999-09-27
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-08-13
End date: 2008-08-13
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Sensipar; Renal [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Aspirin; Hydrocodone Bitartrate + Acetaminophen; Phoslo; Calcium Acetate; Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron; Renvela
Possible Optimark side effects in 57 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31
Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Fatigue, Anhedonia, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Extremity Contracture, Peau D'orange, Pain in Extremity, Excoriation, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Hypoaesthesia, Skin Hypopigmentation, DRY Skin, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Scar, Skin Fibrosis, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging Renal
Start date: 2005-08-25
End date: 2005-08-25
Omniscan
Dosage: unk, once
Indication: Angiogram Peripheral
Start date: 2005-08-30
End date: 2005-08-30
Omniscan
Dosage: unk, once
Start date: 2005-09-28
End date: 2005-09-29
Omniscan
Dosage: unk, once
Start date: 2005-11-03
End date: 2005-11-03
Omniscan
Dosage: unk, once
Start date: 2005-10-03
End date: 2005-10-03
Optimark
Dosage: 19 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-04-20
End date: 2005-04-20
Omniscan
Dosage: unk
Omniscan
Dosage: unk, once
Start date: 2005-10-01
End date: 2005-10-01
Omniscan
Dosage: unk, once
Start date: 2005-10-18
End date: 2005-10-18
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-03-17
End date: 2006-03-17
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-08
End date: 2005-09-08
Omniscan
Dosage: unk, once
Start date: 2005-09-06
End date: 2005-09-06
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk, once
Indication: Venogram Renal
Start date: 2005-09-01
End date: 2005-09-01
Omniscan
Dosage: unk, once
Start date: 2005-10-21
End date: 2005-10-21
Optimark
Dosage: 19 ml, once
Start date: 2005-07-05
End date: 2005-07-05
Other drugs received by patient: Viagra; Oxycodone Hydrochloride; Lisinopril; Mirapex; Sodium Citrate; Prednisone TAB; Norvasc; Zaroxolyn; Lasix; Compazine; Aspirin; Folic Acid; Spiriva; Calcitriol; Ativan; Cytoxan; Acetaminophen; Pentamidine Isethionate; Albuterol; Calcitonin Salmon; Phoslo; Lexapro; Pravachol; Labetalol HCL; MS Contin; Lopressor; Thiamine; Trazodone HCL; Protonix; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Kayexalate; Darbepoetin Alfa; Wellbutrin; Normodyne; Coumadin; Flagyl; Heparin; Magnesium Oxide; Fosamax
Possible Optimark side effects in 51 year old female
Reported by a lawyer from United States on 2012-05-31
Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)
Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Joint Stiffness, Skin Fissures, Dermatitis, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Skin Haemorrhage, Injury, Pain in Extremity, Motor Dysfunction, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Sclerodactylia, Burning Sensation, Anxiety, Emotional Distress, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Omniscan
Indication: Venogram
Optimark
Indication: Venogram
Magnevist
Dosage: unk, once
Indication: Venous Pressure Increased
Start date: 2004-12-09
End date: 2004-12-09
Magnevist
Indication: Arteriovenous Fistula Operation
Start date: 2006-11-28
End date: 2006-11-28
Magnevist
Indication: Dialysis Device Insertion
Multihance
Indication: Fistulogram
Prohance
Indication: Fistulogram
Magnevist
Indication: Dialysis Efficacy Test
Start date: 2006-09-26
End date: 2006-09-26
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Fistulogram
Prohance
Indication: Venogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2001-01-11
End date: 2001-01-11
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Fistulogram
Multihance
Indication: Venogram
Other drugs received by patient: Levothroid; Atenolol; Vicodin; Immune Globulin NOS; Tramadol HCL; Protonix; Pravachol; Sensipar; Sensipar; Imodium; Immune Globulin NOS; Benadryl; Fosrenol; Nitroglycerin; Corticosteroids; Calcium Carbonate; Renagel; Phoslo; Immune Globulin NOS; Immune Globulin NOS; Loperamide; Protonix; Nephro-Vite [vitamins Nos]; Allopurinol; Allopurinol; Cyclosporine; Acetaminophen; Benadryl; Coumadin; Epoetin NOS; Vitamin B12; Immune Globulin NOS; Acetaminophen; Ureacin; Omeprazole; Amiodarone HCL; Procardia XL; Prilosec; Nifedipine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Metoclopramide; Levothroid; Coumadin; Coumadin; Calcium Carbonate; Plendil; Acetaminophen; Acetaminophen; Acetaminophen; Benadryl; PEG-3350 and Electrolytes; Cardizem; Prednisone TAB; Atenolol; Reglan; Renagel; Epogen; Pravastatin; Metoprolol Tartrate
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-30
Patient: 56 year old female
Reactions: Joint Contracture, Pain, Abasia, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Depression, Injury, Extremity Contracture, Muscular Weakness, Skin Disorder, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Deformity, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Dermal Cyst, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Optimark
Indication: Disorientation
Magnevist
Dosage: unk
Indication: Renal Mass
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Headache
Optimark
Indication: Muscular Weakness
Other drugs received by patient: Renvela; Prednisone; Lantus; Sensipar; Atenolol; Prograf
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29
Patient: 56 year old female
Reactions: Pruritus, Abasia, Joint Contracture, Pain, Skin Hyperpigmentation, Ephelides, Joint Stiffness, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Depression, Fibrosis, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, Muscular Weakness, General Physical Health Deterioration, Skin Disorder, Skin Induration, Nephrogenic Systemic Fibrosis, Rash, DRY Skin, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Indication: Disorientation
Optimark
Indication: Headache
Magnevist
Indication: Renal Mass
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Muscular Weakness
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-05-28
End date: 1999-05-28
Other drugs received by patient: Lantus; Sensipar; Phoslo; Procrit; Renvela; Prograf; Atenolol; Slow Release Iron; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Prednisone TAB
Possible Optimark side effects in 57 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25
Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Anhedonia, Fatigue, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Peau D'orange, Pain in Extremity, Excoriation, Muscle Contracture, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Hypoaesthesia, Skin Hypopigmentation, DRY Skin, Skin Induration, Skin Tightness, Skin Plaque, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Skin Fibrosis, Scar
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk, once
Start date: 2005-10-18
End date: 2005-10-18
Omniscan
Dosage: unk, once
Start date: 2005-10-21
End date: 2005-10-21
Optimark
Dosage: 19 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-04-20
End date: 2005-04-20
Omniscan
Dosage: unk, once
Start date: 2005-10-01
End date: 2005-10-01
Omniscan
Dosage: unk, once
Start date: 2005-09-06
End date: 2005-09-06
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-08
End date: 2005-09-08
Omniscan
Dosage: unk, once
Start date: 2005-09-28
End date: 2005-09-29
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-03-17
End date: 2006-03-17
Omniscan
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging Renal
Start date: 2005-08-25
End date: 2005-08-25
Omniscan
Dosage: unk, once
Indication: Venogram Renal
Start date: 2005-09-01
End date: 2005-09-01
Omniscan
Dosage: unk, once
Indication: Angiogram Peripheral
Start date: 2005-08-30
End date: 2005-08-30
Omniscan
Dosage: unk, once
Start date: 2005-11-03
End date: 2005-11-03
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk, once
Start date: 2005-10-03
End date: 2005-10-03
Omniscan
Dosage: unk
Optimark
Dosage: 19 ml, once
Start date: 2005-07-05
End date: 2005-07-05
Other drugs received by patient: Cytoxan; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Pentamidine Isethionate; Oxycodone HCL; Wellbutrin; Coumadin; Lopressor; Aspirin; Folic Acid; Flagyl; Acetaminophen; Zaroxolyn; Normodyne; Compazine; Pravachol; Albuterol; Ativan; MS Contin; Fosamax; Thiamine; Calcitriol; Norvasc; Lasix; Darbepoetin Alfa; Heparin; Protonix; Calcitonin Salmon; Labetalol HCL; Renagel; Phoslo; Viagra; Sodium Citrate; Trazodone HCL; Mirapex; Spiriva; Prednisone TAB; Magnesium Oxide; Kayexalate; Lexapro; Lisinopril
Possible Optimark side effects in 42 year old female
Reported by a physician from United States on 2012-05-23
Patient: 42 year old female
Reactions: Pain, Muscle Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Skin Hypertrophy, Skin Tightness, Joint Range of Motion Decreased, Pigmentation Disorder, Musculoskeletal Stiffness, Fibrosis
Drug(s) suspected as cause:
Optimark
Indication: Diagnostic Procedure
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2008-11-20
Magnevist
Indication: Diagnostic Procedure
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Diagnostic Procedure
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Indication: Headache
Other drugs received by patient: Darunavir Hydrate; Oxycodone HCL; Isentress; Dapsone; Phoslo; Toprol-XL
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-16
Patient: 56 year old female
Reactions: Pain, Joint Contracture, Abasia, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Depression, Extremity Contracture, Skin Disorder, Muscular Weakness, General Physical Health Deterioration, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Deformity, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Dermal Cyst, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Indication: Renal Mass
Optimark
Indication: Muscular Weakness
Optimark
Indication: Disorientation
Optimark
Indication: Headache
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-06-02
End date: 2006-06-02
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-05-21
End date: 2004-05-21
Other drugs received by patient: Sensipar; Atenolol; Prednisone TAB; Prograf; Renvela; Lantus
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-15
Patient: 56 year old female
Reactions: Pain, Abasia, Joint Contracture, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Injury, Depression, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Nephrogenic Systemic Fibrosis, Skin Induration, DRY Skin, Deformity, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Dermal Cyst, Scar, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Headache
Optimark
Indication: Disorientation
Magnevist
Dosage: unk
Indication: Renal Mass
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Indication: Muscular Weakness
Other drugs received by patient: Lantus; Sensipar; Prednisone; Atenolol; Prograf; Renvela
Possible Optimark side effects in 49 year old male
Reported by a physician from United States on 2012-05-11
Patient: 49 year old male, weighing 76.4 kg (168.0 pounds)
Reactions: Pruritus, Pain, Skin Hyperpigmentation, Muscle Tightness, Pruritus Generalised, Myalgia, Fatigue, Skin Discolouration, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Muscle Spasms, Dyspnoea, Pain in Extremity, Muscular Weakness, Hypoaesthesia, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Hypertrophy, Deformity, Exercise Tolerance Decreased, Skin Tightness, Joint Swelling, Arthralgia, Gait Disturbance, Asthenia, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-06-24
End date: 1999-06-24
Magnevist
Start date: 2002-08-28
End date: 2002-08-28
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-10-14
End date: 2004-10-14
Magnevist
Start date: 2002-09-27
End date: 2002-09-27
Magnevist
Start date: 2002-12-30
End date: 2002-12-30
Magnevist
Start date: 2002-09-03
End date: 2002-09-03
Optimark
Start date: 2005-10-17
End date: 2005-10-17
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2002-09-27
Gadolinium IN Unspecified Drug
Dosage: 1980's
Other drugs received by patient: Alprazolam; Zolpidem; Fluoxetine; Oxycodone HCL; Azithromycin; Prozac; Sertraline Hydrochloride; Furosemide; Lipitor; Diazepam; Visipaque; Proscar; Ciprofloxacin; Trazodone HCL; Hydrochlorothiazide; Meperidine HCL; Ketoconazole; Prilosec; Prochlorperazine; Dexamethasone; Hydromorphone HCL
Possible Optimark side effects in 42 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10
Patient: 42 year old female
Reactions: Pain, Muscle Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Hypertrophy, Skin Tightness, Joint Range of Motion Decreased, Pigmentation Disorder, Musculoskeletal Stiffness, Fibrosis
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Diagnostic Procedure
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Diagnostic Procedure
Omniscan
Indication: Diagnostic Procedure
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2008-11-20
Gadolinium IN Unspecified Drug
Indication: Headache
Other drugs received by patient: Dapsone; Toprol-XL; Phoslo; Isentress; Oxycodone HCL; Darunavir Hydrate
Possible Optimark side effects in 31 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10
Patient: 31 year old female, weighing 59.8 kg (131.6 pounds)
Reactions: Pruritus, Pain, Joint Contracture, Skin Burning Sensation, Muscle Spasticity, Joint Stiffness, Myalgia, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Skin Swelling, Pain in Extremity, Muscle Contracture, Muscular Weakness, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Stress, Skin Tightness, Finger Deformity, Anxiety, Arthralgia, Exfoliative Rash, Gait Disturbance, Atrophy
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Multihance
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk
Indication: Angiogram
Start date: 2003-01-10
End date: 2003-01-10
Prohance
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging Brain
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2007-01-18
End date: 2007-01-18
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-22
End date: 2003-09-22
Other drugs received by patient: Amlodipine Besylate; Accupril; Ibuprofen; Renagel; Cardura; Depakote; Amiodarone HCL; Elavil; Pravastatin; Labetalol HCL; Phenytoin; Aspirin; Metoprolol Tartrate; Morphine; Plendil; Lovenox; Methadone HCL; Lidocaine; Vitamin K TAB; Clonidine; Heparin; Lamictal; Folic Acid; Enoxaparin; Promethazine; Norvasc; Cardizem; Coumadin; Prednisone TAB; Diazepam; Dilantin; Vicodin; Xanax
Possible Optimark side effects in 82 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-08
Patient: 82 year old female, weighing 69.8 kg (153.7 pounds)
Reactions: Pain, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Hyperpigmentation, Hypoaesthesia, Deformity, Muscle Tightness, Skin Tightness, Skin Plaque, Pruritus Generalised, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Asthenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Prohance
Indication: Diagnostic Procedure
Magnevist
Indication: Diagnostic Procedure
Optimark
Indication: Diagnostic Procedure
Multihance
Indication: Diagnostic Procedure
Omniscan
Indication: Diagnostic Procedure
Contrast Media
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Xalatan; Multivitamins and Iron; Colchicine; Aspirin; Lotrel; Meloxicam; Alphagan; Cosopt; Plavix; Hydrochlorothiazide; Cyproheptadine HCL; Amlodipine Besylate and Benazepril HCL; Lovenox
Possible Optimark side effects in 82 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-08
Patient: 82 year old female, weighing 69.8 kg (153.7 pounds)
Reactions: Pain, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Induration, Hypoaesthesia, Skin Hyperpigmentation, Deformity, Muscle Tightness, Skin Tightness, Skin Plaque, Pruritus Generalised, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Asthenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Indication: Diagnostic Procedure
Multihance
Indication: Diagnostic Procedure
Contrast Media
Indication: Product Used FOR Unknown Indication
Optimark
Indication: Diagnostic Procedure
Omniscan
Indication: Diagnostic Procedure
Prohance
Indication: Diagnostic Procedure
Other drugs received by patient: Plavix; Hydrochlorothiazide; Xalatan; Meloxicam; Colchicine; Aspirin; Lovenox; Cosopt; Alphagan; Multivitamins and Iron; Cyproheptadine HCL; Amlodipine Besylate and Benazepril HCL; Lotrel
Possible Optimark side effects in 69 year old male
Reported by a physician from United States on 2012-05-08
Patient: 69 year old male, weighing 99.0 kg (217.8 pounds)
Reactions: Pruritus, Joint Contracture, Pain, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Musculoskeletal Stiffness, Fibrosis, Extremity Contracture, Peau D'orange, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Skin Tightness, Burning Sensation, Gait Disturbance, Asthenia, Cardiovascular Disorder, Skin Fibrosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Back Pain
Start date: 2001-03-20
End date: 2001-03-20
Magnevist
Dosage: 10 ml, unk
Indication: Angioplasty
Start date: 2002-10-02
End date: 2002-10-02
Prohance
Indication: Angiogram
Magnevist
Dosage: 10 ml, unk
Start date: 2004-12-02
End date: 2004-12-02
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2002-02-04
End date: 2002-02-04
Optimark
Indication: Angiogram
Multihance
Indication: Angiogram
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2001-05-17
End date: 2001-05-17
Omniscan
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 10 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-08-25
End date: 2006-08-25
Magnevist
Dosage: 20 ml, unk
Indication: Stent Placement
Start date: 2003-05-14
End date: 2003-05-14
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2002-03-27
End date: 2002-03-27
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 20 ml, unk
Start date: 2002-09-09
End date: 2002-09-09
Magnevist
Dosage: 20 ml, unk
Start date: 2004-10-19
End date: 2004-10-19
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Potassium Chloride; Cardura; Aspirin; Norvasc; Demadex; Zetia; Spironolactone; Clonidine; Diltiazem; Epogen; Isosorbide Dinitrate; Quinine Sulfate; Lisinopril; Minoxidil; Nephrocaps
Possible Optimark side effects in 57 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-03
Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Anhedonia, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Skin Lesion, Musculoskeletal Stiffness, Injury, Peau D'orange, Pain in Extremity, Muscular Weakness, Hypoaesthesia, DRY Skin, Skin Hypertrophy, Skin Hypopigmentation, Nephrogenic Systemic Fibrosis, Skin Plaque, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Omniscan
Dosage: unk, once
Indication: Venogram Renal
Start date: 2005-09-01
End date: 2005-09-01
Omniscan
Dosage: unk, once
Start date: 2005-09-28
End date: 2005-09-29
Omniscan
Dosage: unk, once
Start date: 2005-11-03
End date: 2005-11-03
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk unk, once
Indication: Renal Scan
Start date: 2005-08-25
End date: 2005-08-25
Optimark
Dosage: 19 ml, once
Start date: 2005-07-05
End date: 2005-07-05
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-08
End date: 2005-09-08
Omniscan
Dosage: unk, once
Start date: 2005-10-01
End date: 2005-10-01
Omniscan
Dosage: unk, once
Start date: 2005-10-18
End date: 2005-10-18
Optimark
Dosage: 19 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-04-20
End date: 2005-04-20
Omniscan
Dosage: unk, once
Indication: Angiogram Peripheral
Start date: 2005-08-30
End date: 2005-08-30
Omniscan
Dosage: unk
Omniscan
Dosage: unk, once
Start date: 2005-10-03
End date: 2005-10-03
Omniscan
Dosage: unk, once
Start date: 2005-10-21
End date: 2005-10-21
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-03-17
End date: 2006-03-17
Omniscan
Dosage: unk, once
Start date: 2005-09-06
End date: 2005-09-06
Other drugs received by patient: Pravachol; Sodium Citrate; Kayexalate; Oxycodone HCL; Aspirin; Prednisone; Calcitonin Salmon; Zaroxolyn; MS Contin; Lexapro; Lisinopril; Coumadin; Pentamidine; Compazine; Spiriva; Ativan; Norvasc; Lasix; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Flagyl; Calcitriol; Labetalol HCL; Phoslo; Normodyne; Lopressor; Thiamine; Cytoxan; Wellbutrin; Viagra; Heparin; Trazodone HCL; Protonix; Darbepoetin Alfa; Fosamax; Folic Acid; Albuterol; Acetaminophen; Magnesium Oxide; Mirapex
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-02
Patient: 56 year old female
Reactions: Pain, Joint Contracture, Abasia, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Injury, Fibrosis, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Skin Induration, DRY Skin, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Skin Plaque, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Disorientation
Optimark
Indication: Muscular Weakness
Magnevist
Dosage: unk
Indication: Renal Mass
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Indication: Headache
Other drugs received by patient: Prograf; Sensipar; Prednisone; Atenolol; Renvela; Lantus
Page 1 Next >>
|